These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 23599127)
1. Comparative evaluation of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for detecting and identifying human papillomaviruses in archival tissue specimens of head and neck cancers. Kocjan BJ; Maver PJ; Hosnjak L; Zidar N; Odar K; Gale N; Poljak M Acta Dermatovenerol Alp Pannonica Adriat; 2012 Dec; 21(4):73-5. PubMed ID: 23599127 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for the detection of human papillomaviruses in formalin-fixed, paraffin-embedded cervical cancer specimens. Kocjan BJ; Seme K; Poljak M J Virol Methods; 2011 Jul; 175(1):117-9. PubMed ID: 21513740 [TBL] [Abstract][Full Text] [Related]
3. Comparison of HPV sign genotyping test with INNO-LiPA HPV genotyping extra assay on histologic and cytologic cervical specimens. Barbieri D; Nocera M; Gallinella G; Gentilomi GA; Plazzi M; Costa S; Santini D; Venturoli S Diagn Microbiol Infect Dis; 2012 Sep; 74(1):43-8. PubMed ID: 22717156 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the AdvanSure HPV GenoBlot assay with the INNO-LiPA HPV genotyping assay for human papillomavirus genotyping. Chung HS; Lee M J Clin Virol; 2014 May; 60(1):34-8. PubMed ID: 24636736 [TBL] [Abstract][Full Text] [Related]
5. Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes. Barzon L; Militello V; Pagni S; Palù G J Clin Virol; 2012 Nov; 55(3):256-61. PubMed ID: 22877561 [TBL] [Abstract][Full Text] [Related]
6. Comparison of SPF10 real-time PCR and conventional PCR in combination with the INNO-LiPA HPV Genotyping Extra assay for the detection and typing of human papillomavirus in cervical samples. Micalessi MI; Boulet GA; Pillet S; Jacquet J; Pozzetto B; Bogers JJ; Bourlet T J Virol Methods; 2013 Dec; 194(1-2):113-7. PubMed ID: 23978605 [TBL] [Abstract][Full Text] [Related]
7. The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra. Geraets DT; Struijk L; Kleter B; Molijn A; van Doorn LJ; Quint WG; Colau B J Virol Methods; 2015 Apr; 215-216():22-9. PubMed ID: 25698462 [TBL] [Abstract][Full Text] [Related]
8. Exfoliated cells of the oral mucosa for HPV typing by SPF10 in head and neck cancer. Morbini P; Dal Bello B; Alberizzi P; Mannarini L; Mevio N; Bertino G; Benazzo M J Virol Methods; 2012 Dec; 186(1-2):99-103. PubMed ID: 22989407 [TBL] [Abstract][Full Text] [Related]
9. Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes. Seme K; Lepej SZ; Lunar MM; Iscić-Bes J; Planinić A; Kocjan BJ; Vince A; Poljak M J Clin Virol; 2009 Oct; 46(2):176-9. PubMed ID: 19683958 [TBL] [Abstract][Full Text] [Related]
10. HPV detection and genotyping of head and neck cancer biopsies by molecular testing with regard to the new oropharyngeal squamous cell carcinoma classification based on HPV status. Veyer D; Wack M; Grard O; Bonfils P; Hans S; Bélec L; Badoual C; Péré H Pathology; 2019 Jun; 51(4):421-425. PubMed ID: 31005250 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the HPV typing INNO-LiPA EXTRA assay on formalin-fixed paraffin-embedded cervical biopsy samples. Alberizzi P; Spinillo A; Gardella B; Cesari S; Silini EM J Clin Virol; 2014 Dec; 61(4):535-9. PubMed ID: 25464970 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples. Jentschke M; Soergel P; Hillemanns P J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925 [TBL] [Abstract][Full Text] [Related]
13. [HPV DNA genotyping: A study of anogenital, head and neck and skin cancers in a population from west Algerian. HPV detection in different cancers from an Algerian population]. Nahet A; Boublenza L; Hassaine H; Masdoua N; Prétet JL; Belglaiaa E; Mougin C Bull Cancer; 2016 May; 103(5):455-60. PubMed ID: 27085765 [TBL] [Abstract][Full Text] [Related]
14. Comparison between two human papillomavirus genotyping assays targeting the L1 or E6/E7 region in cervical cancer biopsies. Martró E; Valencia MJ; Tarrats A; Castellà E; Llatjós M; Franquesa S; Matas L; Ausina V Enferm Infecc Microbiol Clin; 2012 May; 30(5):225-9. PubMed ID: 22133414 [TBL] [Abstract][Full Text] [Related]
15. Principles and analytical performance of Abbott RealTime High Risk HPV test. Huang S; Tang N; Mak WB; Erickson B; Salituro J; Li Y; Krumpe E; Schneider G; Yu H; Robinson J; Abravaya K J Clin Virol; 2009 Jul; 45 Suppl 1():S13-7. PubMed ID: 19651363 [TBL] [Abstract][Full Text] [Related]
16. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381 [TBL] [Abstract][Full Text] [Related]
17. Comparison of INNO-LiPA HPV Genotyping v2 with PCR product subcloning and sequencing for identification of genital human papillomavirus genotypes in African women. Didelot-Rousseau MN; Courgnaud V; Nagot N; Ouedraogo A; Konate I; Mayaud P; Weiss H; Van de Perre P; Segondy M J Virol Methods; 2006 Aug; 135(2):181-5. PubMed ID: 16675035 [TBL] [Abstract][Full Text] [Related]
18. Comparison of In-House Multiplex Real Time PCR, Diagcor GenoFlow HPV Array Test and INNO-LiPA HPV Genotyping Extra Assays with LCD- Array Kit for Human Papillomavirus Genotyping in Cervical Liquid Based Cytology Specimens and Genital Lesions in Tehran, Iran. Sohrabi A; Rahnamaye-Farzami M; Mirab-Samiee S; Mahdavi S; Babaei M Clin Lab; 2016; 62(4):615-9. PubMed ID: 27215080 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Abbott RealTime High-Risk HPV and Hybrid Capture 2 Assays for Detection of HPV Infection. Ko K; Yu S; Lee EH; Park H; Woo HY; Kwon MJ Ann Clin Lab Sci; 2016 Sep; 46(5):522-8. PubMed ID: 27650620 [TBL] [Abstract][Full Text] [Related]
20. The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studies. Poljak M; Oštrbenk A Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(2):43-7. PubMed ID: 23836358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]